FUT9 and cancer: Following this approach, we successfully generated FUT4- or FUT9-expressing MC38 glyco-engineered cell lines and examined changes in their respective glycosylation profiles, focusing on biosynthesis of the fucosylated Lewisx determinant and its impact on the cancer cell glycome.